Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ottawa Hospital Research Institute
Vall d'Hebron Institute of Oncology
Samyang Biopharmaceuticals Corporation
University of Nebraska
Leap Therapeutics, Inc.
Fate Therapeutics
University of Nebraska
Barbara Ann Karmanos Cancer Institute
Aileron Therapeutics, Inc.
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine
Dana-Farber Cancer Institute
Karolinska University Hospital
Sun Yat-sen University
Leo W. Jenkins Cancer Center
GlaxoSmithKline
ETOP IBCSG Partners Foundation
The Netherlands Cancer Institute
Prescient Therapeutics, Ltd.
NSABP Foundation Inc
Louisiana State University Health Sciences Center Shreveport
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
AstraZeneca
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Centre Jean Perrin
Eske Corporation S.A.C
Masonic Cancer Center, University of Minnesota
Emory University
Shanghai Jiao Tong University School of Medicine
Emory University
Barbara Ann Karmanos Cancer Institute
Duke University
Hoosier Cancer Research Network
Hellenic Oncology Research Group
Hellenic Oncology Research Group
HaEmek Medical Center, Israel
UNICANCER
M.D. Anderson Cancer Center
EMD Serono
Jules Bordet Institute
National Cancer Centre, Singapore
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
Cancer Research UK